Votubia
Novartis’ brain tumour drug Votubia launched in UK
September 29, 2011Sales and Marketing Afinitor, Votubia
Novartis has launched its orphan drug Votubia in the UK for patients with a rare type of brain tumour. Votubia …
Everolimus approved to treat rare tumour disease
September 8, 2011Sales and Marketing Novartis, SEGA, Votubia, everolimus
Novartis has gained EU approval for everolimus to be used to treat a rare non-cancerous tumour. Everolimus is already marketed …
Novartis’ Votubia reduces benign brain tumours in SEGA patients
July 11, 2011Research and Development Novartis, SEGA, Votubia, everolimus
Novartis’ novel cancer drug Votubia has reduced the size of SEGA brain tumours in a late-stage trial. Votubia (or everolimus …
Afinitor stops tumour growth in advanced breast cancer
July 5, 2011Manufacturing and Production, Research and Development Afinitor, Novartis, Votubia, advanced breast cancer
Novartis’ Afinitor has impressed in a late-stage trial by increasing survival in women with advanced breast cancer. The phase III …
Regulators back Novartis’ Votubia
June 28, 2011Sales and Marketing Novartis, Votubia, everolimus
Novartis’ drug Votubia has been recommended by regulators to treat a disease for which the only current option in Europe …
Latest content
Jager-van Dijk is new Arletta Pharma Solutions CEOÂ
Tridem begins phase Ib trial of Parkinson’s disease vaccine
Trio become latest Symbiosis commercial additions
UK immunoglobulin supply faces growing pressure, report warns
